Navigation Links
Berg Diagnostics Launches Molecular Diagnostics Services and Products at American Association for Cancer Research (AACR) 102nd Annual Meeting
Date:4/4/2011

ORLANDO, Fla., April 4, 2011 /PRNewswire/ -- Berg Diagnostics, a member of the Berg Pharma, Inc group of companies with Berg Biosystems and Cytotech Labs, is a Boston-based molecular diagnostics company that officially launched its molecular diagnostics services and products at AACR meeting from April 2nd – 6th in Orlando, Florida.

(Logo: http://photos.prnewswire.com/prnh/20110404/CL76832LOGO)

The company offers enabling technologies such as high-throughput omics-based molecular profiling, biomarker validation, and regulated bioanalysis, facilitating its client base to decipher differential molecular signatures between normal and disease states, reveal underlying pathophysiology, identify and validate novel biomarkers. In addition, it has its proprietary proteomic, lipidomic, and metabolomic platforms that allow for an integrative data-driven approach to diagnostics.

Dr. Renu Virmani, LTC, MC (US Army), President and Medical Director of CV Path in Gaithlesnburg, MD, Clinical Professor of Pathology at Georgetown University, and former Chair, Division of Cardiovascular Pathology, Armed Forces Institute of Pathology commented, "These Technologies will likely discover new biomarkers, which should help treat patients get individualized medicine."

"We are very excited to showcase our research capabilities and product offerings to cancer researchers worldwide," explained Shen Luan, President and CTO of Berg Diagnostics. "The successful delivery of molecular diagnostics is the foundation of personalized medicine. Berg Diagnostics is well-positioned to translate the promise of personalized medicine into palpable human impact."

In addition, a product portfolio of over 100 research-based ELISA kits would be unveiled at Booth # 177. The list of ELISA kits covers research categories such as angiogenesis, apoptosis, endocrinology, immunology, inflammation, oncology, and signal transduction.  Complete product catalogs are found on the new Berg Diagnostics website.

"Shen has been able to combine the latest cutting edge 'omic' platforms to enable biological mining to the deepest layers of understanding.  The company is poised to be an industry leader in actually separating signal from noise in analyzing biological samples which will be the foundation of truly enabling personalized medicine," noted Niven R. Narain, President and CTO of Berg Biosystems, and Co-founder of Berg Diagnostics.

About Berg Diagnostics LLC

Berg Diagnostics is a Boston-based molecular diagnostics company that offers high-throughput omics-based molecular profiling, biomarker validation, and regulated bioanalysis to accelerate development of molecular therapeutics and diagnostics. Armed with the state-of-the-art instrumentation platforms, the company serves to catalyze project end-points in therapeutic and biomarker development.


'/>"/>
SOURCE Berg Diagnostics LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing
2. U.S. Department of Energy Hails Dilon Diagnostics as a Medical Technology Pioneer and Top National Innovator
3. Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis
4. Quest Diagnostics Commences Tender Offer for Acquisition of Celera
5. Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives
6. Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR
7. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
8. Quest Diagnostics to Acquire Celera, Strengthening Position as Worlds Leading Innovator in Molecular Diagnostics and Development
9. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China
10. Reportlinker Adds Global Biosensors in Medical Diagnostics Industry
11. ResearchDx Launches Contract Diagnostics Organization (CDO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 Persistence Market ... global market for intraoperative imaging, excerpts from which ... US$ 513.9 million. According to the report, the ... the grounds of increasing adoption of minimally-invasive surgeries ... diagnostic imaging for neurosurgeries. The world,s leading medical ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Cardiac Prosthetic ... 9.2% over the next decade to reach approximately $8.9 billion by ... forecasts for all the given segments on global as well as ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing designer ... stand solutions representative to the Minneapolis Home and Garden Show which is being held ... is garnering national attention is the Minneapolis Convention Center. , From its broad ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came time to ... in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand opening presented ... $51 million to purchase and renovate the 185,000 square-foot office complex, which was ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy ... The technology is so cutting edge, in fact, the U.S. Food and Drug ... procedures. However, successful patient outcomes in certain clinical stem cell procedures have shown ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... certification exam and eligibility requirements effective with the April 2017 testing period. NACCM, ... , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ensure ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... analytics to accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, ... This new solution helps transform the HCC Risk Adjustment process from a ...
Breaking Medicine News(10 mins):